These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19030736)

  • 1. Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil.
    Daher EF; Evangelista LF; Silva Júnior GB; Lima RS; Aragão EB; Arruda GA; Galeano NM; Mota RM; Oliveira RA; Silva SL
    Braz J Infect Dis; 2008 Aug; 12(4):329-32. PubMed ID: 19030736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.
    Sayyahfar S; Ansari S; Mohebali M; Behnam B
    Korean J Parasitol; 2014 Apr; 52(2):189-91. PubMed ID: 24850963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
    Laguna F; López-Vélez R; Pulido F; Salas A; Torre-Cisneros J; Torres E; Medrano FJ; Sanz J; Picó G; Gómez-Rodrigo J; Pasquau J; Alvar J
    AIDS; 1999 Jun; 13(9):1063-9. PubMed ID: 10397536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.
    Silveira LJ; Rocha TJ; Ribeiro SA; Pedrosa CM
    Rev Inst Med Trop Sao Paulo; 2015; 57(1):33-8. PubMed ID: 25651324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis with pericarditis in an HIV-infected patient.
    Mofredj A; Guerin JM; Leibinger F; Masmoudi R
    Scand J Infect Dis; 2002; 34(2):151-3. PubMed ID: 11928856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An 8-Year Retrospective Study of Human Visceral Leishmaniasis.
    Barbosa JF; de Figueiredo SM; Lyon S; Caligiorne RB
    Curr Clin Pharmacol; 2016; 11(4):265-269. PubMed ID: 27659611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
    Daher EF; Fonseca PP; Gerhard ES; Leitão TM; Silva Júnior GB
    J Parasitol; 2009 Jun; 95(3):652-5. PubMed ID: 19642802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kala azar with disseminated dermal leishmaniasis.
    Kumar PV; Sadeghi E; Torabi S
    Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Visceral leishmaniasis (kala-azar) on Ilha de São Luís, Maranhão. Brazil: its evolution and outlook].
    da Silva AR; Viana GM; Varonil C; Pires B; Nascimento Mdo D; Costa JM
    Rev Soc Bras Med Trop; 1997; 30(5):359-68. PubMed ID: 9380895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudo-acute transformation of an idiopathic myelofibrosis due to kala-azar.
    Disdier P; Swiader L; Serratrice J; Mary C; Weiller PJ
    Br J Haematol; 1998 Feb; 100(2):449. PubMed ID: 9488642
    [No Abstract]   [Full Text] [Related]  

  • 12. Post-kala-azar dermal leishmaniasis associated with AIDS.
    Bittencourt A; Silva N; Straatmann A; Nunes VL; Follador I; Badaró R
    Braz J Infect Dis; 2002 Dec; 6(6):313-6. PubMed ID: 12585976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Visceral childhood leishmaniasis: diagnosis and treatment].
    Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
    An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
    Torre-Cisneros J; Villanueva JL; Kindelan JM; Jurado R; Sanchez-Guijo P
    Clin Infect Dis; 1993 Oct; 17(4):625-7. PubMed ID: 8268341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Visceral leishmaniasis in an immunocompetent subject, acquired in the Pyrenees region].
    Malvy D; Djossou F; Ibanez C; Vatan R; Longy-Boursier M; Le Bras M
    Presse Med; 2006 Jun; 35(6 Pt 1):987-8. PubMed ID: 16783261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
    Dursun O; Erişir S; Yeşilipek A
    Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric visceral leishmaniasis in southern France.
    Minodier P; Piarroux R; Garnier JM; Unal D; Perrimond H; Dumon H
    Pediatr Infect Dis J; 1998 Aug; 17(8):701-4. PubMed ID: 9726344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of kala azar.
    Ozsoylu S
    Lancet; 1996 Jun; 347(9016):1701. PubMed ID: 8642997
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative analysis of pediatric and adult visceral leishmaniasis in Brazil.
    Rocha NA; Oliveira MJ; Franco LF; Júnior GB; Alves MP; Sampaio AM; Montenegro BR; Vieira AP; Jacinto CN; Abreu KL; Daher EF
    Pediatr Infect Dis J; 2013 May; 32(5):e182-5. PubMed ID: 23249921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.